Industry News:

Innovaro Pharmalicensing

Latest: Watch here for details of new products and services.

About Us: Innovaro Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Pay-per-Click New!; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Innovaro Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Innovaro Pharmalicensing
is a division of
Innovaro Europe Ltd

Innovaro Corporation

Industry news

Related news

Latest News

Nanosphere Verigene(R) SP Respiratory Virus Panel Categorized as Moderate Complexity by FDA

Teva To Acquire Ratiopharm

Sun Pharma announces USFDA approval for generic Prometh

The Medicines Company Expands a Nationwide Recall for Certain Lots of Cleviprex(R) That May Contain Particulate Matter

Otsuka Pharmaceutical and Acucela Receive FDA Fast Track Designation for ACU-4429 in Patients with Dry AMD

Greatbatch Medical Receives 510(k) Clearance of OptiSeal

FDA Seeks Permanent Injunction Against Louisiana Sprout Grower5

FDA Update on the Investigation into the Salmonella Montevideo Outbreak

Nabi Biopharmaceuticals Initiates Second Phase III Study for NicVAX as an Aid to Smoking Cessation and Long-term Abstinence

FDA Approves First Totally Implanted Hearing System

More news... | RSS Feed...

Most Viewed

Agendia Receives New York State Laboratory Permit and Laboratory Accreditation by College of American Pathologists

FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date

Novartis drug Tasigna

Novartis oral multiple sclerosis development compound Gilenia

FDA Announces Possible Safety Concern for HIV Drug Combination

Advanced Cell Technology's RPE Cells Granted Orphan Drug Status from FDA for Treatment of Stargardt's Macular Dystrophy

InterMune Announces Submission of MAA for Pirfenidone for the Treatment of Patients With IPF

Epigenomics AG: Blood Test for Colorectal Cancer Now Available Nationwide in Germany and Switzerland

InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Pirfenidone

Exenatide Once Weekly New Drug Application Review Extended By FDA Due to Weather-Related Closure

Clients in focus...

Get the Flash Player to see this rotator.

BioTrinity

Press releases: Innovaro Pharmalicensing current industry press releases.

Products:	Partnering Search	Pay-per-Click	Company Profiling	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us

© Copyright 1998-2010 Innovaro Pharmalicensing, a division of Innovaro Europe Ltd All rights reserved. Terms and Conditions | Contact us